CFR1 receptor antagonists for the treatment of congenital adrenal cortex hyperplasia

• 收藏
• 分享

专利权人:

НЬЮРОКРАЙН БАЙОСАЙЕНСИЗ; ИНК. (US)

发明人:

ГРИГОРИАДИС, Димитри, Э. (US)

申请号：

RU2020112197

公开号：

RU2020112197A

申请日:

2015.01.21

申请国别(地区):

RU

年份:

2020

代理人:

摘要：

CRF1 receptor antagonists have the potential to directly inhibit ACTH release in patients with CAH and thereby allow normalization of androgen production while using lower, more physiologic doses of hydrocortisone, and thus reducing treatment-associated side effects.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/